Techasupaboon, Tanyanop
Vasikasin, Vasin
Varothai, Narittaya
Raknaisil, Navee
Nasomsong, Worapong http://orcid.org/0000-0002-3486-8591
Article History
Received: 6 June 2022
Accepted: 27 August 2022
First Online: 6 September 2022
Declarations
:
: The study was reviewed and approved by the Institutional Review Board, Royal Thai Army Medical Department in compliance with the Declaration of Helsinki, the Belmont Report, CIOMS Guidelines and the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use—Good Clinical Practice (ICH-GCP), approval number R071h/63. Informed consent was obtained in written from all participants in the study.
: Not applicable.
: The authors declare they have no potential conflict of interest relevant to this article.